Navigation Links
Third generation Small pox vaccine from Cell-culture

Richard Greenberg and colleagues compared their Cell culture small pox vaccine// (CCSV) derived from cell culture with calf lymph derived vaccine. Small pox vaccine currently used is a live, attenuated vaccine virus derived from calf lymph. This vaccine produces adverse effects in vaccinated, 15-42 develop serious or life threatening adverse reactions of every million. 1 to 2 people every million die because of this vaccine. Serious side include eczema vaccinatum, progressive vaccinia, post vaccinal encephalitis, fetal vaccine, vaccina keratitis, myopericarditis.

Small pox vaccine is contraindicated in up to 30% or more population, including infants, pregnant women, immunocompromised, eczema patients, and cardiovascular conditions.

In this trial, the safety and immunogenecity, adverse effects were determined by neutralization, Antibody titers, T-cell proliferative response assays and interferon-? elispot. Only one vaccinated person developed pock lesions. The number of participants who became immune to the virus was high, with increased measures of cell mediated immunity in CCSV recipients. These results show CCSV vaccine is equally immunogenic and safe compared to calf lymph derived vaccine.

This new vaccine can solve the problem of calf lymph vaccine, as these existing stocks of calf lymph vaccine are mot than 20 years old, contamination by bovine prions can be avoided, unwanted immune response to bovine and other non-vaccina entities in vaccine.

Though, CCSV has advantages, we should be able to provide universal pre-exposure immunity to small pox. A safe, immunogenic, effective vaccine will provide a barrier against attempts to use small pox as a biological weapon. Research leading to the third generation vaccines, such as vaccinia viruses that are further attenuated, inactivated viruses, subunit or peptide based vaccines should have significant use to public health.


'"/>




Page: 1

Related medicine news :

1. Third artificial heart patient introduced
2. Surgery Offers Better Treatment For Third Degree Piles
3. One Third Of All Cancers Preventable!
4. Britain Announces Third Transfusion Related Mad Cow Case
5. Kleins Third Way Has Tough Opposition
6. Ignorance about AIDS rampart in Third of College Students: Chinese survey
7. Jalgaon: Third Phase Of Culling Operations Begin
8. Pramod Mahajan Undergoes Third Surgery
9. Third Arm Removed Successfully
10. Erection Drug Was Not Useful to Two-Thirds of Its Users
11. Babies Could Be exposed to Third Hand Smoke If Parents Are Smokers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... , ... Trusted debt-reduction firm CreditAssociates, LLC has announced two important milestones. To ... $835 million in resolved debt for its clients. , Credit card debt, unpaid hospital ... of debt settled by the company. With more than a decade of combined service ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... winners of the Entrepreneur Innovation Awards (EIA), held this past Thursday night at ... Connecticut-based companies and entrepreneurs, presented their innovative project ideas to a panel of ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... of Professional Benefit Administrators (SPBA) hosted “Expanding Your Success” with an educational ... as it focused on best practices for third party administrators (TPAs) related to ...
(Date:9/19/2017)... ... ... The Semper Fi Fund, one of the nation’s highest-rated veteran nonprofits serving ... and a compelling documentary that provide unique insights and powerful advice to help address ... ongoing mission. , Each of the videos focuses on a specific issue that’s highly ...
(Date:9/19/2017)... Toronto, Ontario (PRWEB) , ... September 19, 2017 , ... ... governmental regulation of pollutants have fallen on deaf ears, leaving the water industry itself ... one company that stays ahead of the curve in the field of natural ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)... SAN FRANCISCO , Sept. 12, 2017 /PRNewswire/ ... Lifecycle Management Solutions (VLMS), is pleased to announce ... as a member of its Board of Directors ... 2017. ValGenesis VLMS enables life science companies to ... eliminate the use of paper in this process. ...
(Date:9/7/2017)... , Sept. 7, 2017  Eli Lilly and ... actions to streamline operations to more efficiently focus ... its cost structure. Global workforce reductions, including those ... expected to impact approximately 3,500 positions. ... expects annualized savings of approximately $500 million that ...
Breaking Medicine Technology: